AYOXXA today announced that it has signed a research agreement with one of the leading pharmaceutical companies. The agreement targets the development of low volume and high sensitivity multiplex assays for aqueous humor protein profiling for biomarker identification and validation in support of drug discovery in ophthalmology. The collaboration reflects an initial phase of a multi study plan in the field of ophthalmology and is a further step to establish AYOXXA LUNARISTM system as the standard for biomarker identification and validation in translational proteomics.